Scholars Central

Conference abstractPublished 21 Nov 2016

Evaluation chemotherapeutic in tumor stem cells of head and neck cancer cell lines

Authors: Glaucia Maria M Fernandes, Ana Livia S Galbiatti-Dias, Carlos Henrique V Nascimento Filho, Rosa S Kawasaki Oyama, Erika Cristina Pavarino, Jose Victor Maniglia, Joao A Padovani Junior, Andre L

Faculdade de Medicina de SÃ?£o JosÃ?© do Rio Preto, Brazil

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: Head and neck cancer (HNC) is the sixth most common type of cancer with low survival rate. Despite therapeutic advances, the treatment still show negative outcomes related to chemoresistance and relapses/metastasis. The reasons for this to occur can include the presence of tumor stem cells (TSC) involved in the initiation of malignancy development and tumor metastasis Aim: The purpose of the present study is to evaluate the effectiveness of chemotherapies (Docetaxel, 5-Fluorouracil, Paclitaxel) in head and neck cell lines. Methodology & Theoretical Orientation: Two cell lines of head and neck cancer, HEP-2-laryngeal carcinoma and HN13-oral cavity carcinoma were cultured. After, it has been marked with CD44+ and then separated by fluorescence activated cell sorting (FACS) equipament. This CD44 positive subpopulation was considered as the TSC. TSCs separated were cultivated in 6-well plates. Then, the cells were exposed chemotherapeutic treatment. After 24h the cells viability was determined by trypan blue exclusion. Statistical analyzes were performed to T Student using Bioestat v5.3 Software and were considered significant p<0.05. Findings: No statistical difference was shown with or without chemotherapeutic treatment (Docetaxel: p=0.1891; 5-fluorouracil: p=0.2154; Taxol: p=0.2008). The percentage of viable cells after chemotherapeutic treatment compared to control was Docetaxel:58.36%; 5-fluorouracil: 65.48%; Paclitaxel: 11.55%. Conclusion & Significance: The chemotherapy drugs used in the study do not seem to be effective in the elimination of CD44 positive subpopulation in HNC cell lines. Moreover, paclitaxel treatment induces tumor stem cells death though, it was not observed in statistical analysis. Our findings show that chemotherapeutic drugs do not show effectiveness in CD44 positive subpopulation of HNC. Therefore, it is required development of novel drugs TSC-targeting agents.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Glaucia Maria M Fernandes”
  • BylineArticles whose byline prints “Ana Livia S Galbiatti-Dias”
  • BylineArticles whose byline prints “Carlos Henrique V Nascimento Filho”
  • BylineArticles whose byline prints “Rosa S Kawasaki Oyama”
  • BylineArticles whose byline prints “Erika Cristina Pavarino”
  • BylineArticles whose byline prints “Jose Victor Maniglia”
  • BylineArticles whose byline prints “Joao A Padovani Junior”
  • BylineArticles whose byline prints “Andre L”